Published in Neurology on May 10, 2005
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2010) 7.93
Cancer linked to Alzheimer disease but not vascular dementia. Neurology (2009) 4.83
Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol (2008) 2.10
Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol (2009) 1.86
Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.78
Association of alcohol consumption with brain volume in the Framingham study. Arch Neurol (2008) 1.71
Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology (2012) 1.66
The role of higher-level cognitive function in gait: executive dysfunction contributes to fall risk in Alzheimer's disease. Dement Geriatr Cogn Disord (2007) 1.65
Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry (2009) 1.54
Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci (2013) 1.27
Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis (2010) 1.22
Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension. J Cereb Blood Flow Metab (2013) 1.16
Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology (2008) 1.08
Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics (2011) 0.97
Role of 20-HETE, TRPC channels, and BKCa in dysregulation of pressure-induced Ca2+ signaling and myogenic constriction of cerebral arteries in aged hypertensive mice. Am J Physiol Heart Circ Physiol (2013) 0.96
Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer disease. AJNR Am J Neuroradiol (2010) 0.92
Synergistic effects of hypertension and aging on cognitive function and hippocampal expression of genes involved in β-amyloid generation and Alzheimer's disease. Am J Physiol Heart Circ Physiol (2013) 0.92
IGF-1 deficiency impairs cerebral myogenic autoregulation in hypertensive mice. J Cereb Blood Flow Metab (2014) 0.91
Small vessel versus large vessel vascular dementia: risk factors and MRI findings. J Neurol (2008) 0.91
Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)-MRI trial. J Clin Hypertens (Greenwich) (2010) 0.90
Hippocampal volume is an independent predictor of cognitive performance in CADASIL. Neurobiol Aging (2007) 0.90
Risk of dementia and death in the long-term follow-up of the Pittsburgh Cardiovascular Health Study-Cognition Study. Alzheimers Dement (2015) 0.87
Circulating omega-3 polyunsaturated fatty acids and subclinical brain abnormalities on MRI in older adults: the Cardiovascular Health Study. J Am Heart Assoc (2013) 0.87
Caspase-Cleaved Tau Co-Localizes with Early Tangle Markers in the Human Vascular Dementia Brain. PLoS One (2015) 0.85
Characteristics of MR infarcts associated with dementia and cognitive function in the elderly. Neuroepidemiology (2011) 0.84
Vascular health, diabetes, APOE and dementia: the Aging, Demographics, and Memory Study. Alzheimers Res Ther (2010) 0.82
Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture. Alzheimers Dement (2011) 0.82
Is apolipoprotein E4 an important risk factor for vascular dementia? Int J Clin Exp Pathol (2014) 0.81
Aging Exacerbates Pressure-Induced Mitochondrial Oxidative Stress in Mouse Cerebral Arteries. J Gerontol A Biol Sci Med Sci (2015) 0.81
Mediterranean diet and cognitive decline over time in an elderly Mediterranean population. Eur J Nutr (2014) 0.81
Cerebral white matter hyperintensities in the prediction of cognitive decline and incident dementia. Int Rev Psychiatry (2013) 0.81
Connecting cardiovascular disease and dementia: further evidence. J Am Heart Assoc (2013) 0.78
Concordance rates for cognitive impairment among older African American twins. Alzheimers Dement (2009) 0.76
Does Stroke Contribute to Racial Differences in Cognitive Decline? Stroke (2015) 0.75
High daytime and nighttime ambulatory pulse pressure predict poor cognitive function and mild cognitive impairment in hypertensive individuals. J Cereb Blood Flow Metab (2016) 0.75
Enhancing detection of subclinical end-organ damage: echocardiographic left ventricular strain holds up a mirror to the brain. Circulation (2013) 0.75
Multi-Infarct Dementia: A Historical Perspective. Dement Geriatr Cogn Dis Extra (2017) 0.75
Hypertension and cognitive impairment. Ann Transl Med (2017) 0.75
A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers. J Alzheimers Dis (2017) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology (1992) 5.95
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology (2004) 3.61
Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology (2003) 3.19
Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci (2002) 3.11
A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. AJNR Am J Neuroradiol (1994) 3.07
Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke (2002) 3.05
Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology (2003) 2.97
Imaging cerebral atrophy: normal ageing to Alzheimer's disease. Lancet (2004) 2.81
Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol (1998) 2.77
Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology (2001) 2.55
White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke (2004) 2.50
Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol (2003) 2.36
Amyloid angiopathy-related vascular cognitive impairment. Stroke (2004) 2.21
Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology (1997) 2.13
Risk factors for vascular dementia and Alzheimer disease. Stroke (2004) 1.92
Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke (2004) 1.74
Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population. J Am Geriatr Soc (2004) 1.69
Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults : the Cardiovascular Health Study. CHS Collaborative Research Group. Arterioscler Thromb Vasc Biol (1999) 1.66
Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. J Neurol Neurosurg Psychiatry (1999) 1.63
Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke (2004) 1.17
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10
Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health (1998) 9.58
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.68
Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.51
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology (2009) 7.04
Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci (2000) 6.54
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 5.12
Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology (2007) 4.14
Risk of Alzheimer's disease and duration of NSAID use. Neurology (1997) 4.06
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA (2000) 3.99
Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US study. Neurology (1998) 3.82
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74
Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology (2007) 3.71
Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology (2007) 3.67
HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology (2001) 3.55
Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology (1993) 3.53
Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry (1997) 3.48
Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology (1988) 3.40
Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry (2001) 3.32
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology (2007) 3.26
Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J (2001) 3.22
Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol (2000) 3.05
Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol (2000) 2.99
Incidence of Alzheimer's disease in a rural community in India: the Indo-US study. Neurology (2001) 2.99
Predicting risk of dementia in older adults: The late-life dementia risk index. Neurology (2009) 2.92
Longitudinal volumetric MRI change and rate of cognitive decline. Neurology (2005) 2.90
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology (2008) 2.80
Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology (2000) 2.79
White matter lesions impair frontal lobe function regardless of their location. Neurology (2004) 2.77
Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology (2000) 2.73
Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology (1998) 2.70
Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry (2000) 2.70
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology (2007) 2.65
Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I. Neurology (2000) 2.64
Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med (1997) 2.62
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology (2011) 2.61
Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. Neurology (2007) 2.56
Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology (2001) 2.55
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology (2007) 2.54
Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology (2002) 2.52
Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology (1999) 2.52
Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol (2001) 2.51
Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol (1989) 2.49
Context processing in older adults: evidence for a theory relating cognitive control to neurobiology in healthy aging. J Exp Psychol Gen (2001) 2.49
Generalized tensor-based morphometry of HIV/AIDS using multivariate statistics on deformation tensors. IEEE Trans Med Imaging (2008) 2.46
Systematic review of the effect of psychological interventions on family caregivers of people with dementia. J Affect Disord (2006) 2.45
Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol (1997) 2.43
The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA (1999) 2.42
Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology (2010) 2.41
Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology (2001) 2.41
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology (2009) 2.37
Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology (2002) 2.35
Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology (2005) 2.18
Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS) Neurology (1990) 2.17
Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging (1990) 2.14
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology (2001) 2.11
The development of a tool to assess neonatal pain. Neonatal Netw (1993) 2.08
The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry (1999) 2.07
Vascular factors predict rate of progression in Alzheimer disease. Neurology (2007) 2.06
Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology (2007) 2.05
Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Arch Neurol (2000) 2.04
Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis (1990) 2.04
Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project. Neurology (2000) 2.03
Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry (2008) 1.99
Occupational exposure to pesticides increases the risk of incident AD: the Cache County study. Neurology (2010) 1.95
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology (1995) 1.92
Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology (2002) 1.91
NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology (2007) 1.88
Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology (1994) 1.88
Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc (1998) 1.88
Free testosterone and risk for Alzheimer disease in older men. Neurology (2004) 1.88
Atrophy rates of entorhinal cortex in AD and normal aging. Neurology (2003) 1.88
Genome-wide association study of Alzheimer's disease. Transl Psychiatry (2012) 1.88
Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med (1988) 1.87
Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset. Neurology (2004) 1.87
Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry (2005) 1.83
The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. Int J Geriatr Psychiatry (2012) 1.82
Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Crit Care Med (2000) 1.82
Age, Alzheimer disease, and brain structure. Neurology (2009) 1.75
Serum cholesterol and risk of Alzheimer disease: a community-based cohort study. Neurology (2005) 1.75
Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology (2006) 1.75
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study. Neurology (2008) 1.71